Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OLMETEC PLUS | 25MG 40MG | TABLET | Resolved | 2019-03-12 | 2019-10-02 | 78424 |
| OLMETEC PLUS | 25MG 40MG | TABLET | Resolved | 2019-10-03 | 2020-02-28 | 95399 |
| OLMETEC PLUS | 25MG 40MG | TABLET | Resolved | 2022-10-03 | 2022-12-15 | 170960 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2019-02-11 | 2019-03-02 | 75262 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2020-03-26 | 2020-04-03 | 109442 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2023-11-22 | 2024-01-17 | 211081 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2024-02-26 | 2024-03-09 | 220663 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Actual shortage | 2024-04-22 | 2024-04-23 | 225881 |
| CANDESARTAN HCT | 12.5MG 16MG | TABLET | Avoided shortage | 2018-11-12 | 2018-12-03 | 66686 |
| CANDESARTAN HCT | 12.5MG 16MG | TABLET | Resolved | 2019-05-17 | 2019-07-19 | 84315 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
| RAMIPRIL-HCTZ | Discontinued | 2018-12-21 | 2018-12-22 | 70392 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 |